Dept. of Nephrology and Immunology Dept. of Nephrology and Immunology San Carlo Borromeo Hospital - MilanSan Carlo Borromeo Hospital - Milan

Giuseppe D’Amico MD, FRCPGiuseppe D’Amico MD, FRCP

OPPORTUNITIES FOR A CHRONIC DISEASE OPPORTUNITIES FOR A CHRONIC DISEASE OUTREACH PROGRAM IN CHINAOUTREACH PROGRAM IN CHINA

Bellagio, ISN Conference, March 26-28, 2004Bellagio, ISN Conference, March 26-28, 2004

0200400600800

10001200140016001800

USA Japan Taiwan HongKong

MainlandChina

Patients on Regular Dialysis Treatment at the end of 2002 (prevalence per million of population)

Greater China Region

(288 millions) (127 millions) (22.5 millions)

(7 millions) (1300 millions)

A full dialysis treatment program in Mainland China, similar to that already existing in Taiwan, assuming a comparable prevalence of ESRF (genetic background is identical), would imply that regular dialysis treatment should be made available to more than 2 million patients, an annual total cost for the Central Government of 100 billion dollars.The number of patients that should be treated in Mainland China alone is double that of the total number of patients being treated now in the entire world.

GUANGHZOU

HONGKONG

ZHUHAI

MACAU